| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| clodronic acid | adp/atp translocase 1 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Lytic lesion[MeSHID:D010014] Neoplasm Metastasis[MeSHID:D009362] Malignant Bone Neoplasm[MeSHID:D001859] Humoral hypercalcemia of malignancy (disorder)[MeSHID:C562390] |
NA | approved,investigational,vet_approved | inhibitor |
| clodronic acid | adp/atp translocase 2 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Lytic lesion[MeSHID:D010014] Neoplasm Metastasis[MeSHID:D009362] Malignant Bone Neoplasm[MeSHID:D001859] Humoral hypercalcemia of malignancy (disorder)[MeSHID:C562390] |
NA | approved,investigational,vet_approved | inhibitor |
| clodronic acid | adp/atp translocase 3 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Lytic lesion[MeSHID:D010014] Neoplasm Metastasis[MeSHID:D009362] Malignant Bone Neoplasm[MeSHID:D001859] Humoral hypercalcemia of malignancy (disorder)[MeSHID:C562390] |
NA | approved,investigational,vet_approved | inhibitor |
| clodronic acid | hydroxylapatite | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Lytic lesion[MeSHID:D010014] Neoplasm Metastasis[MeSHID:D009362] Malignant Bone Neoplasm[MeSHID:D001859] Humoral hypercalcemia of malignancy (disorder)[MeSHID:C562390] |
NA | approved,investigational,vet_approved | antagonist |
| click here to return to the previous page | ||||||||